Gang Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gang Qin has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
Yi Shen
Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Nantong, China
12 shared publicationsXun Zhuang
Department of Epidemiology and Biostatistics, School of Public Health of Nantong University, Nantong, China
11 shared publicationsJian-Guo Shao
Center for Liver Diseases, Nantong Third People's Hospital, Nantong University, 60 Mid-Youth Road, Nantong, 226006, Jiangsu, China
10 shared publicationsSheng Zhang
Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Nantong, China
6 shared publicationsXu-Lin Wang
Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Nantong, China
6 shared publications- Yin-Hua Jiang
Department of Medical Genetics, Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, China
6 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Prevalence of poor vision and its associated factors among middle school students: a cross-sectional study
Poor vision is a global public health challenge, with rising prevalence and earlier onset among Chinese adolescents. This study analyzed the prevalence and
- 10 March 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessPrevalence of poor vision and its associated factors among middle school students: a cross-sectional study
Poor vision is a global public health challenge, with rising prevalence and earlier onset among Chinese adolescents. This study analyzed the prevalence and
- Open Access
- 16 January 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Public awareness, knowledge and attitudes toward thalassemia and its screening in five high-prevalence countries: a cross-sectional study based on an online survey
Thalassemia is a significant public health issue in many high-prevalence countries. Despite progress in thalassemia management, limited public awareness an
- 16 January 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessPublic awareness, knowledge and attitudes toward thalassemia and its screening in five high-prevalence countries: a cross-sectional study based on an online survey
Thalassemia is a significant public health issue in many high-prevalence countries. Despite progress in thalassemia management, limited public awareness an
- Open Access
- 19 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (2) , 103055
Enhanced immune recovery with B/F/TAF compared with DTG/3TC in HIV patients: A prospective observational study
- 19 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (2) , 103055
Open AccessEnhanced immune recovery with B/F/TAF compared with DTG/3TC in HIV patients: A prospective observational study
- Open Access
- 29 September 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-10
Predicting treatment outcomes in drug-sensitive pulmonary tuberculosis patients in rural eastern China
This study aimed to identify risk factors associated with unsuccessful treatment outcomes among newly diagnosed drug-sensitive pulmonary tuberculosis (PTB) patients in rural eastern China and to develop a prediction model for treatment outcomes. This study analyzed 838 newly diagnosed drug-sensitive PTB patients in rural eastern China (2021–2023). Treatment outcomes (unsuccessful treatment) were assessed using WHO guidelines. The cohort was randomly divided into a training set (70%) and a validation set (30%) for internal validation. Multivariate logistic regression identified predictors, including age, malnutrition, comorbidities, hemoglobin levels, and sputum smear grades. Decision curve analysis (DCA) was performed to evaluate the clinical utility of the prediction model by quantifying the net benefit across a range of threshold probabilities. The prediction model identified six independent predictors of unsuccessful treatment outcomes: diabetes, chronic lung disease, alcohol use, hypoalbuminemia, anemia, and sputum smear grades. The area under the receiver operating characteristic curve (AUC) was 0.754 (95% CI: 0.676–0.833), indicating good discriminative ability. The model demonstrated moderate accuracy across three risk categories. A nomogram was developed to visually represent the model, enabling clinicians to estimate individual patient risk based on these six predictors. Additionally, an online calculator was created to facilitate easy and practical application of the model in clinical settings. Decision curve analysis (DCA) further validated the clinical utility of the model, showing a significant net benefit across a wide range of threshold probabilities (2–54%), supporting its applicability for guiding clinical decision-making. The prediction model serves as a valuable tool for clinicians to identify high-risk PTB patients and tailor interventions effectively. This approach can enhance treatment strategies and contribute to better TB control in rural eastern China.
- 29 September 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-10
Open AccessPredicting treatment outcomes in drug-sensitive pulmonary tuberculosis patients in rural eastern China
This study aimed to identify risk factors associated with unsuccessful treatment outcomes among newly diagnosed drug-sensitive pulmonary tuberculosis (PTB) patients in rural eastern China and to develop a prediction model for treatment outcomes. This study analyzed 838 newly diagnosed drug-sensitive PTB patients in rural eastern China (2021–2023). Treatment outcomes (unsuccessful treatment) were assessed using WHO guidelines. The cohort was randomly divided into a training set (70%) and a validation set (30%) for internal validation. Multivariate logistic regression identified predictors, including age, malnutrition, comorbidities, hemoglobin levels, and sputum smear grades. Decision curve analysis (DCA) was performed to evaluate the clinical utility of the prediction model by quantifying the net benefit across a range of threshold probabilities. The prediction model identified six independent predictors of unsuccessful treatment outcomes: diabetes, chronic lung disease, alcohol use, hypoalbuminemia, anemia, and sputum smear grades. The area under the receiver operating characteristic curve (AUC) was 0.754 (95% CI: 0.676–0.833), indicating good discriminative ability. The model demonstrated moderate accuracy across three risk categories. A nomogram was developed to visually represent the model, enabling clinicians to estimate individual patient risk based on these six predictors. Additionally, an online calculator was created to facilitate easy and practical application of the model in clinical settings. Decision curve analysis (DCA) further validated the clinical utility of the model, showing a significant net benefit across a wide range of threshold probabilities (2–54%), supporting its applicability for guiding clinical decision-making. The prediction model serves as a valuable tool for clinicians to identify high-risk PTB patients and tailor interventions effectively. This approach can enhance treatment strategies and contribute to better TB control in rural eastern China.
- Open Access
- 2 July 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-14
Epidemiological characteristics and socioeconomic factors of sexually transmitted infections in China during 2002–2021
Sexually transmitted infections (STIs), including HIV, gonorrhea, and syphilis, pose significant public health challenges globally. In China, rising STI incidences are associated with rapid urbanization and changing sexual behaviors. This study aims to analyze the trends and socioeconomic factors of these three STIs in China. Incidence data for HIV, gonorrhea, and syphilis from 31 provinces (2002–2021) were obtained from the China Hygiene and Health Statistics Yearbook. JoinPoint regression was used to assess trends, hotspot analysis to identify spatial clusters, global principal component analysis (GPCA) to reduce data dimensionality, and a panel fixed-effects model (FEM) to identify influential factors. The annual average percentage changes (AAPCs) in incidence were 20.68% for HIV, - 2.37% for gonorrhea, and 11.55% for syphilis. Hotspot analysis revealed persistent HIV clusters in western provinces, gonorrhea clusters in the eastern coastal and parts of central provinces, and expanding syphilis clusters from western and central provinces to the entire country. GPCA extracted three components, explaining 83% of the overall variance. PA1 includes factors such as nighttime light data (NLD) and population density (PD). PA2 includes passenger volume (PAX), the working-age population aged 15–64 (P15-64) and the number of healthcare institutions (HCIs). PA3 encompasses GDP per capita (pGDP) and the sex ratio (SR). FEM analysis showed that socioeconomic factors had varying impacts on the three STIs. HIV was negatively associated with PA1 (β = - 1.049, P < 0.05) and positively associated with PA2 (β = 0.614, P < 0.001), and negatively associated with PA3 (β = - 0.721, P < 0.001). Gonorrhea was positively associated with PA1 (β = 16.005, P < 0.001) and PA2 had strong positive correlations in most regions, while PA3 was not significant nationally. Syphilis had a negative association with PA3 at the national level (β = - 5.517, P < 0.001). This study demonstrates temporal and spatial variations in STI epidemiology in China from 2002 to 2021, reflecting socioeconomic development disparities. The findings highlight the need for geographically and socioeconomically tailored interventions to improve STI control strategies.
- 2 July 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-14
Open AccessEpidemiological characteristics and socioeconomic factors of sexually transmitted infections in China during 2002–2021
Sexually transmitted infections (STIs), including HIV, gonorrhea, and syphilis, pose significant public health challenges globally. In China, rising STI incidences are associated with rapid urbanization and changing sexual behaviors. This study aims to analyze the trends and socioeconomic factors of these three STIs in China. Incidence data for HIV, gonorrhea, and syphilis from 31 provinces (2002–2021) were obtained from the China Hygiene and Health Statistics Yearbook. JoinPoint regression was used to assess trends, hotspot analysis to identify spatial clusters, global principal component analysis (GPCA) to reduce data dimensionality, and a panel fixed-effects model (FEM) to identify influential factors. The annual average percentage changes (AAPCs) in incidence were 20.68% for HIV, - 2.37% for gonorrhea, and 11.55% for syphilis. Hotspot analysis revealed persistent HIV clusters in western provinces, gonorrhea clusters in the eastern coastal and parts of central provinces, and expanding syphilis clusters from western and central provinces to the entire country. GPCA extracted three components, explaining 83% of the overall variance. PA1 includes factors such as nighttime light data (NLD) and population density (PD). PA2 includes passenger volume (PAX), the working-age population aged 15–64 (P15-64) and the number of healthcare institutions (HCIs). PA3 encompasses GDP per capita (pGDP) and the sex ratio (SR). FEM analysis showed that socioeconomic factors had varying impacts on the three STIs. HIV was negatively associated with PA1 (β = - 1.049, P < 0.05) and positively associated with PA2 (β = 0.614, P < 0.001), and negatively associated with PA3 (β = - 0.721, P < 0.001). Gonorrhea was positively associated with PA1 (β = 16.005, P < 0.001) and PA2 had strong positive correlations in most regions, while PA3 was not significant nationally. Syphilis had a negative association with PA3 at the national level (β = - 5.517, P < 0.001). This study demonstrates temporal and spatial variations in STI epidemiology in China from 2002 to 2021, reflecting socioeconomic development disparities. The findings highlight the need for geographically and socioeconomically tailored interventions to improve STI control strategies.
- Open Access
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e002522
Health and economic evaluation of cytomegalovirus vaccination strategy among young women in China: a modelling study
Background: Congenital cytomegalovirus (cCMV) infection imposes a substantial economic burden on both families and society in China. There is currently a paucity of dynamic models to study cytomegalovirus (CMV) vaccination strategies for China’s high-seroprevalence population (over 95%). Recent clinical trials demonstrated that the messenger RNA (mRNA) vaccine candidate, mRNA-1647, exhibited potential efficacy in both preinfection and postinfection contexts. This study aims to assess the cost-effectiveness of various CMV vaccination strategies for Chinese young women. Method: An age-structured dynamic model was adopted, using Mathematica software, to simulate three strategies: (1) no vaccination (status quo); (2) pre-marriage vaccination (age 20–28 years); (3) reproductive-age vaccination (age 20–40 years). The vaccine was assumed to have 50% coverage and 50% efficacy for the first 5 years, with efficacy gradually decreasing over the next 15 years, costing US$300 per treatment course. This study period covers 2025–2050. Health outcomes included reductions in cCMV infection incidence, morbidity and mortality. We conducted cost-effectiveness, scenario and sensitivity analyses, discounting costs and disability-adjusted life years (DALYs) at 3% annually. The strategy would be considered cost-effective if the incremental cost-effectiveness ratio (ICER) was below China’s 2023 per capita gross domestic product (US$12 675). Results: By 2050, pre-marriage and reproductive-age vaccination strategies could prevent cCMV infection incidence by 38.8% (95% uncertainty interval [UI], 33.7% to 43.5%) and 43.3% (38.3% to 47.1%), respectively, with ICERs of US$4751 (4124 to 5378) and US$10 814 (10 290 to 11 338) per DALY averted compared with the status quo. However, the reproductive-age strategy is not cost-effective, with an ICER of US$25 553 (12 566 to 36 126) versus the pre-marriage strategy. Conclusions: Prioritising pre-marriage vaccination could control cCMV infection in China. Our findings would inform public health policies and guide future research on optimising CMV vaccination strategies.
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e002522
Open AccessHealth and economic evaluation of cytomegalovirus vaccination strategy among young women in China: a modelling study
Background: Congenital cytomegalovirus (cCMV) infection imposes a substantial economic burden on both families and society in China. There is currently a paucity of dynamic models to study cytomegalovirus (CMV) vaccination strategies for China’s high-seroprevalence population (over 95%). Recent clinical trials demonstrated that the messenger RNA (mRNA) vaccine candidate, mRNA-1647, exhibited potential efficacy in both preinfection and postinfection contexts. This study aims to assess the cost-effectiveness of various CMV vaccination strategies for Chinese young women. Method: An age-structured dynamic model was adopted, using Mathematica software, to simulate three strategies: (1) no vaccination (status quo); (2) pre-marriage vaccination (age 20–28 years); (3) reproductive-age vaccination (age 20–40 years). The vaccine was assumed to have 50% coverage and 50% efficacy for the first 5 years, with efficacy gradually decreasing over the next 15 years, costing US$300 per treatment course. This study period covers 2025–2050. Health outcomes included reductions in cCMV infection incidence, morbidity and mortality. We conducted cost-effectiveness, scenario and sensitivity analyses, discounting costs and disability-adjusted life years (DALYs) at 3% annually. The strategy would be considered cost-effective if the incremental cost-effectiveness ratio (ICER) was below China’s 2023 per capita gross domestic product (US$12 675). Results: By 2050, pre-marriage and reproductive-age vaccination strategies could prevent cCMV infection incidence by 38.8% (95% uncertainty interval [UI], 33.7% to 43.5%) and 43.3% (38.3% to 47.1%), respectively, with ICERs of US$4751 (4124 to 5378) and US$10 814 (10 290 to 11 338) per DALY averted compared with the status quo. However, the reproductive-age strategy is not cost-effective, with an ICER of US$25 553 (12 566 to 36 126) versus the pre-marriage strategy. Conclusions: Prioritising pre-marriage vaccination could control cCMV infection in China. Our findings would inform public health policies and guide future research on optimising CMV vaccination strategies.
- Open Access
- 20 December 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 3553
Economic evaluation of short message service intervention for HIV prevention among men who have sex with men in China: a modelling study
BackgroundMen who have sex with men (MSM) globally face a high risk of HIV infection. Previous studies indicate that customized short message service (SMS) interventions could reduce high-risk behaviors that associated with HIV transmission. This study aims to evaluate the health and economic impacts of such interventions among MSM in China.MethodsA decision tree-Markov model was developed for a simulated cohort of 100,000 MSM of 20 years old. We assessed three intervention strategies: (1) routine strategy with standard health information; (2) SMS strategy with customized messages based on individual high-risk behaviors, with 50.1% efficacy and 50% coverage; (3) LEN-LA (lenacapavir long-acting) strategy as pre-exposure prophylaxis (PrEP), with 100% efficacy lasting for 0.5-year and 50% coverage. The study period was 45 years. Primary outcomes included the number of HIV infections and HIV-related deaths. The cost-effectiveness, cost-utility and cost-benefit analyses were conducted along with sensitivity analyses from the healthcare sector perspective.ResultsThe SMS strategy was more effective, averting 6,191 (22.0%) HIV infections and 2,100 (38.5%) HIV-related deaths when compared with routine strategy. The average cost-effectiveness ratios (ACERs) were US$6,361 (95% CI: 5,959-6,613) per HIV infection averted and US$18,752 (95% CI: 17,274 - 20,530) per HIV-related death averted. It had incremental cost-effectiveness ratios (ICERs) of US$1,743 (95% CI: 1,673-1,799) per QALY, with a benefit cost ratio (BCR) of 1.98 (95% CI: 1.94-2.02), compared with routine strategy. While the LEN-LA strategy may be the most effective, its high cost, coupled with the highest ICER, currently presents a considerable obstacle to its widespread adoption. The ICERs were most affected by the probability of HIV infection, intervention cost and coverage.ConclusionsSMS strategy for preventing HIV among MSM in China is cost-effective and could be a promising strategy for HIV prevention. These findings may have implications for public health policy and resource allocation in HIV prevention efforts targeting high-risk populations.
- 20 December 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 3553
Open AccessEconomic evaluation of short message service intervention for HIV prevention among men who have sex with men in China: a modelling study
BackgroundMen who have sex with men (MSM) globally face a high risk of HIV infection. Previous studies indicate that customized short message service (SMS) interventions could reduce high-risk behaviors that associated with HIV transmission. This study aims to evaluate the health and economic impacts of such interventions among MSM in China.MethodsA decision tree-Markov model was developed for a simulated cohort of 100,000 MSM of 20 years old. We assessed three intervention strategies: (1) routine strategy with standard health information; (2) SMS strategy with customized messages based on individual high-risk behaviors, with 50.1% efficacy and 50% coverage; (3) LEN-LA (lenacapavir long-acting) strategy as pre-exposure prophylaxis (PrEP), with 100% efficacy lasting for 0.5-year and 50% coverage. The study period was 45 years. Primary outcomes included the number of HIV infections and HIV-related deaths. The cost-effectiveness, cost-utility and cost-benefit analyses were conducted along with sensitivity analyses from the healthcare sector perspective.ResultsThe SMS strategy was more effective, averting 6,191 (22.0%) HIV infections and 2,100 (38.5%) HIV-related deaths when compared with routine strategy. The average cost-effectiveness ratios (ACERs) were US$6,361 (95% CI: 5,959-6,613) per HIV infection averted and US$18,752 (95% CI: 17,274 - 20,530) per HIV-related death averted. It had incremental cost-effectiveness ratios (ICERs) of US$1,743 (95% CI: 1,673-1,799) per QALY, with a benefit cost ratio (BCR) of 1.98 (95% CI: 1.94-2.02), compared with routine strategy. While the LEN-LA strategy may be the most effective, its high cost, coupled with the highest ICER, currently presents a considerable obstacle to its widespread adoption. The ICERs were most affected by the probability of HIV infection, intervention cost and coverage.ConclusionsSMS strategy for preventing HIV among MSM in China is cost-effective and could be a promising strategy for HIV prevention. These findings may have implications for public health policy and resource allocation in HIV prevention efforts targeting high-risk populations.
- 22 November 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (5) , 1271-1280
Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant Tuberculosis Management Strategies in China
China faces the highest burden of latent multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB). We aim to evaluate the health and economic impacts of Vaccae (a novel TB vaccine) and enhanced drug-resistant TB (DR-TB) management strategies. Using a compartmental model calibrated with national TB data, we evaluated nine interventions from 2025-2050: enhanced DR-TB management (S1); Vaccae vaccination for those with Mycobacterium tuberculosis infection targeting specific age groups (S2: adolescents, S3: adolescents and young adults, S4: working-age adults, S5: elderly); and combined strategies (S6: S2+S1, S7: S3+S1, S8: S4+S1, S9: S5+S1). Vaccae’s efficacy was set at 0.547 for the first five years, and then waning annually by 0.036. Costs were US$28/dose for Vaccae, US$87/test for Xpert MTB/RIF (diagnostic), and US$13,818/course for BPaLM (novel short regimen). Using a cost-effectiveness frontier, we identified the optimal strategy providing the greatest health benefit while remaining cost-effective. Strategy S1 is projected to reduce MDR/RR-TB incidence and mortality by 21% (8%-46%) and 54% (38%-67%) by 2050. The combined strategy S9 (S5+S1) is more effective, reducing the incidence by 44% (35%-61%) and mortality by 68% (52%-78%), with an ICER of US$7,222 (4,460-10,779) per DALY averted compared with S1, highlighting its cost-effectiveness. Additionally, S9 could prevent 24.2 (13.5-32.9) million patient-months of second-line treatment from 2025 to 2050. Prioritizing Vaccae vaccination for the elderly and enhancing DR-TB management offers a promising and cost-effective opportunity to DR-TB control in China. The findings may inform vaccination policies in other low- and middle-income countries with high MDR/RR-TB burden. This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/health-and-economic-impacts-of-introducing-vaccae-and-enhanced-drug-resistant-tuberculosis-management-strategies-in-china-cd823858-f912-498f-a39c-274019d0727f?utm_campaign=tidbitlinkshare&utm_source=ITP
- 22 November 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (5) , 1271-1280
Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant Tuberculosis Management Strategies in China
China faces the highest burden of latent multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB). We aim to evaluate the health and economic impacts of Vaccae (a novel TB vaccine) and enhanced drug-resistant TB (DR-TB) management strategies. Using a compartmental model calibrated with national TB data, we evaluated nine interventions from 2025-2050: enhanced DR-TB management (S1); Vaccae vaccination for those with Mycobacterium tuberculosis infection targeting specific age groups (S2: adolescents, S3: adolescents and young adults, S4: working-age adults, S5: elderly); and combined strategies (S6: S2+S1, S7: S3+S1, S8: S4+S1, S9: S5+S1). Vaccae’s efficacy was set at 0.547 for the first five years, and then waning annually by 0.036. Costs were US$28/dose for Vaccae, US$87/test for Xpert MTB/RIF (diagnostic), and US$13,818/course for BPaLM (novel short regimen). Using a cost-effectiveness frontier, we identified the optimal strategy providing the greatest health benefit while remaining cost-effective. Strategy S1 is projected to reduce MDR/RR-TB incidence and mortality by 21% (8%-46%) and 54% (38%-67%) by 2050. The combined strategy S9 (S5+S1) is more effective, reducing the incidence by 44% (35%-61%) and mortality by 68% (52%-78%), with an ICER of US$7,222 (4,460-10,779) per DALY averted compared with S1, highlighting its cost-effectiveness. Additionally, S9 could prevent 24.2 (13.5-32.9) million patient-months of second-line treatment from 2025 to 2050. Prioritizing Vaccae vaccination for the elderly and enhancing DR-TB management offers a promising and cost-effective opportunity to DR-TB control in China. The findings may inform vaccination policies in other low- and middle-income countries with high MDR/RR-TB burden. This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/health-and-economic-impacts-of-introducing-vaccae-and-enhanced-drug-resistant-tuberculosis-management-strategies-in-china-cd823858-f912-498f-a39c-274019d0727f?utm_campaign=tidbitlinkshare&utm_source=ITP
- Open Access
- 13 November 2024
- Published by Elsevier in Drug Resistance Updates
- Vol. 78, 101172
Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis
- 13 November 2024
- Published by Elsevier in Drug Resistance Updates
- Vol. 78, 101172
Open AccessModeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis